West Pharmaceutical Services (WST) Assets Average (2010 - 2026)

West Pharmaceutical Services' Assets Average history runs 17 years deep, the most recent figure standing at $4.2 billion for Q1 2026.

• In Q1 2026, Assets Average rose 15.4% year-over-year to $4.2 billion; the TTM figure through Mar 2026 stood at $4.2 billion (up 15.4% YoY), while the FY2025 annual figure was $4.0 billion, up 5.89% from the prior year.
• Assets Average came in at $4.2 billion for Q1 2026 at West Pharmaceutical Services, roughly flat from $4.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $4.2 billion in Q1 2026 to a low of $3.3 billion in Q1 2022.
• A 5-year average of $3.7 billion and a median of $3.7 billion in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average climbed 19.43% in 2022 and declined 4.08% in 2024, its largest moves.
• West Pharmaceutical Services' Assets Average stood at $3.5 billion in 2022, then gained by 9.38% to $3.8 billion in 2023, then dropped by 3.5% to $3.7 billion in 2024, then climbed by 14.45% to $4.2 billion in 2025, then grew by 0.05% to $4.2 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $4.2 billion, $4.2 billion, and $4.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison